Compound Dihuang Granule Inhibits Nigrostriatal Pathway Apoptosis in Parkinson’s Disease by Suppressing the JNK/AP-1 Pathway

Compound Dihuang Granule (CDG) is widely used in traditional Chinese medicine (TCM) for the treatment of Parkinson’s disease (PD). It has been shown to alleviate PD symptoms. However, the molecular mechanisms of its action have not been established. To establish the molecular mechanisms of CDG again...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Pharmacol
Main Authors: Wang, Li, Yang, Yu-fang, Chen, Long, He, Zhu-qing, Bi, Dian-yong, Zhang, Lei, Xu, Yan-wu, He, Jian-cheng
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2021
Teme:
Pharmacology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8060647/
https://ncbi.nlm.nih.gov/pubmed/33897417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.621359
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki